Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel class of microtubule-destabilizing agents synthesized and evaluated at Kansas State

Oct. 29, 1998

Difluoronucleoside antineoplastic and antiherpesvirus agents from Lilly

Oct. 29, 1998

Human trials of new liposomal ether lipid approved by FDA

Oct. 28, 1998

Schering-Plough obtains promising results in phase I study of p53 gene therapy for NSCLC

Oct. 28, 1998

Genetronics targets prostate cancer as a new indication for electroporation therapy

Oct. 28, 1998

Clinical, preclinical efficacy of Neovastat featured at recent congress

Oct. 27, 1998

Temodal recommended for approval in E.U.

Oct. 27, 1998

STAR study will compare raloxifene to tamoxifen for reducing risk of breast cancer

Oct. 26, 1998

Thalidomide designated orphan drug for multiple myeloma

Oct. 26, 1998

Camptosar receives final FDA approval for colorectal cancer

Oct. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...